Biotelemetry merger investigation: halper sadeh llp announces investigation into whether the sale of biotelemetry, inc. is fair to shareholders; investors are encouraged to contact the firm – beat

New york--(business wire)--halper sadeh llp, a global investor rights law firm, is investigating whether the sale of biotelemetry, inc. (nasdaq: beat) to royal philips for $72.00 per share in cash is fair to biotelemetry shareholders. halper sadeh encourages biotelemetry shareholders to click here to learn more about their legal rights and options or contact daniel sadeh or zachary halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. the investigation concerns whether b
BEAT Ratings Summary
BEAT Quant Ranking